These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25484108)

  • 41. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
    Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
    Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.
    Gatti D; Viapiana O; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Adami S; Rossini M
    J Bone Miner Res; 2012 Nov; 27(11):2259-63. PubMed ID: 22692843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA.
    Gifre L; Humbert L; Muxi A; Del Rio L; Vidal J; Portell E; Monegal A; Guañabens N; Peris P
    Osteoporos Int; 2018 Jan; 29(1):201-209. PubMed ID: 29043391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis.
    Muschitz C; Kocijan R; Pahr D; Patsch JM; Amrein K; Misof BM; Kaider A; Resch H; Pietschmann P
    Calcif Tissue Int; 2015 Jun; 96(6):477-89. PubMed ID: 25911186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sclerostin: a candidate biomarker of SCI-induced osteoporosis.
    Morse LR; Sudhakar S; Lazzari AA; Tun C; Garshick E; Zafonte R; Battaglino RA
    Osteoporos Int; 2013 Mar; 24(3):961-8. PubMed ID: 22801952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased Serum Wnt Antagonist Levels in Patients With Active Acromegaly.
    Chen H; Huang H; Wang Y; Zhang Y; Liu M; Lou Y; Zhang Z; Zhu D; Li P
    Endocr Pract; 2022 May; 28(5):515-520. PubMed ID: 35123069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths.
    Mora S; Puzzovio M; Giacomet V; Fabiano V; Maruca K; Capelli S; Nannini P; Lombardi G; Zuccotti GV
    Endocrine; 2015 Aug; 49(3):783-90. PubMed ID: 25596857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury.
    Maïmoun L; Couret I; Mariano-Goulart D; Dupuy AM; Micallef JP; Peruchon E; Ohanna F; Cristol JP; Rossi M; Leroux JL
    Calcif Tissue Int; 2005 Jun; 76(6):404-11. PubMed ID: 15812577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study of correlation of level of expression of Wnt signaling pathway inhibitors sclerostin and dickkopf-1 with disease activity and severity in rheumatoid arthritis patients.
    Singh A; Gupta MK; Mishra SP
    Drug Discov Ther; 2019; 13(1):22-27. PubMed ID: 30880318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis.
    Anastasilakis AD; Polyzos SA; Avramidis A; Toulis KA; Papatheodorou A; Terpos E
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):752-7. PubMed ID: 19832854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sclerostin and Dickkopf-1 in renal osteodystrophy.
    Cejka D; Herberth J; Branscum AJ; Fardo DW; Monier-Faugere MC; Diarra D; Haas M; Malluche HH
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):877-82. PubMed ID: 21164019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating sclerostin is elevated in short-term and reduced in long-term SCI.
    Battaglino RA; Sudhakar S; Lazzari AA; Garshick E; Zafonte R; Morse LR
    Bone; 2012 Sep; 51(3):600-5. PubMed ID: 22575440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of the relationship between serum sclerostin and dickkopf-1 protein levels with bone turnover in children and adolescents with type-1 diabetes mellitus.
    Kurban S; Selver Eklioglu B; Selver MB
    J Pediatr Endocrinol Metab; 2022 May; 35(5):673-679. PubMed ID: 35411762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sclerostin and Dkk-1 in patients with ankylosing spondylitis.
    Ustun N; Tok F; Kalyoncu U; Motor S; Yuksel R; Yagiz AE; Guler H; Turhanoglu AD
    Acta Reumatol Port; 2014; 39(2):146-51. PubMed ID: 25111416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis.
    Peng J; Dong Z; Hui Z; Aifei W; Lianfu D; Youjia X
    BMC Musculoskelet Disord; 2021 May; 22(1):480. PubMed ID: 34034718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
    Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
    Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment.
    Ueland T; Olarescu NC; Jørgensen AP; Otterdal K; Aukrust P; Godang K; Lekva T; Bollerslev J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):736-43. PubMed ID: 25459913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status.
    Dovjak P; Dorfer S; Föger-Samwald U; Kudlacek S; Marculescu R; Pietschmann P
    Gerontology; 2014; 60(6):493-501. PubMed ID: 24943689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study.
    Anagnostis P; Vakalopoulou S; Christoulas D; Paschou SA; Papatheodorou A; Garipidou V; Kokkoris P; Terpos E
    Haemophilia; 2018 Mar; 24(2):316-322. PubMed ID: 29194852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.